Your browser doesn't support javascript.
loading
Anti-PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression.
Tritz, Zachariah P; Ayasoufi, Katayoun; Wolf, Delaney M; Owens, Carley A; Malo, Courtney S; Himes, Benjamin T; Fain, Cori E; Goddery, Emma N; Yokanovich, Lila T; Jin, Fang; Hansen, Michael J; Parney, Ian F; Wang, Chensu; Moynihan, Kelly D; Irvine, Darrell J; Wittrup, K Dane; Diaz Marcano, Rosa M; Vile, Richard G; Johnson, Aaron J.
Afiliação
  • Tritz ZP; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.
  • Ayasoufi K; Mayo Clinic Department of Immunology, Rochester, Minnesota.
  • Wolf DM; Mayo Clinic Department of Immunology, Rochester, Minnesota.
  • Owens CA; Mayo Clinic Department of Immunology, Rochester, Minnesota.
  • Malo CS; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.
  • Himes BT; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.
  • Fain CE; Mayo Clinic Department of Neurologic Surgery, Rochester, Minnesota.
  • Goddery EN; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.
  • Yokanovich LT; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.
  • Jin F; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.
  • Hansen MJ; Mayo Clinic Department of Immunology, Rochester, Minnesota.
  • Parney IF; Mayo Clinic Department of Immunology, Rochester, Minnesota.
  • Wang C; Mayo Clinic Department of Immunology, Rochester, Minnesota.
  • Moynihan KD; Mayo Clinic Department of Neurologic Surgery, Rochester, Minnesota.
  • Irvine DJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Wittrup KD; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Diaz Marcano RM; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Vile RG; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Johnson AJ; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Cancer Immunol Res ; 11(6): 763-776, 2023 06 02.
Article em En | MEDLINE | ID: mdl-36921098
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_brain_nervous_system_cancer Assunto principal: Glioblastoma / Glioma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_brain_nervous_system_cancer Assunto principal: Glioblastoma / Glioma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2023 Tipo de documento: Article